Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720602 · ClinicalTrials.gov registry record · NA
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01720602: Completed NA study, sponsored by University of Washington.
NCT01720602 is a NA study that has completed, run by University of Washington. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01720602, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This pilot clinical trial studies vorinostat in treating patients with stage IV breast cancer receiving hormone therapy. Vorinostat may help hormone therapy work better by making tumor cells more sensitive to the drug.
Primary Outcome
A 90% score (Wilson) confidence interval will be computed for the rate of clinical benefit. Clinical benefit according to Recist score is defined as: Stable Disease, Partial Remission or Complete Remission. Lack of clinical benefit is defined as Progressive Disease (increase in target lesion size by 20% or more).
Interventions
- DRUG letrozole
- DRUG vorinostat
- PROCEDURE positron emission tomography
- DRUG anastrozole
- DRUG exemestane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-11 |
| Est. Completion | 2020-01 |
| Phase | NA |
What the finished NCT01720602 record still lists
NCT01720602 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which letrozole is the first listed.
NCT01720602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01720602 about?
NCT01720602 is a clinical study titled "Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy". This pilot clinical trial studies vorinostat in treating patients with stage IV breast cancer receiving hormone therapy. Vorinostat may help hormone therapy work better by making tumor cells more sensitive to the drug.
What is the current status of trial NCT01720602?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-11. Estimated completion is 2020-01.
What interventions are being tested in trial NCT01720602?
The interventions under investigation include: letrozole (DRUG), vorinostat (DRUG), positron emission tomography (PROCEDURE), anastrozole (DRUG), exemestane (DRUG).
Who is sponsoring clinical trial NCT01720602?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01720602's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia